Eruzun, Hasan. 2026. “Sclerosing Cholangitis Associated With dabrafenib–trametinib Therapy: BRAF/MEK Inhibitors Should Be Considered”. Journal of Gastrointestinal and Liver Diseases 35 (1):136-37. https://doi.org/10.15403/jgld-6698.